Analytic Investors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$12.9M Buy
123,308
+74,743
+154% +$7.8M 0.14% 140
2016
Q2
$4.73M Buy
48,565
+36,433
+300% +$3.44M 0.06% 191
2016
Q1
$1.17M Buy
+12,132
New +$1.1M 0.01% 383
2015
Q4
Sell
-15,929
Closed -$1.48M 635
2015
Q3
$1.48M Buy
15,929
+6,002
+60% +$571K 0.02% 319
2015
Q2
$923K Buy
+9,927
New +$926K 0.01% 389

Other funds holding CME

Analytic Investors's CME Position: Q3 2016 in Review

Analytic Investors increased its CME Group (CME) stake by 154% in Q3 2016, buying an estimated $7.8M and bringing the position to 123,308 shares worth $12.9M. The position accounts for 0.14% of the portfolio, ranked #140.

Analytic Investors first reported a position in CME in Q2 2015 and has held it in 5 quarters since. 692 funds tracked by Wall St. Rank hold CME as of Q3 2016.

  • Analytic Investors held 123,308 shares of CME Group worth $12.9M as of Q3 2016.
  • Analytic Investors bought 74,743 CME Group shares in Q3 2016, an estimated $7.8M.
  • CME Group made up 0.14% of Analytic Investors's portfolio in Q3 2016, its #140 holding.
  • Analytic Investors first reported a position in CME Group in Q2 2015 and has held it in 5 quarters since.
  • 692 funds tracked by Wall St. Rank held CME Group as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.